“Next step, in light of this data, is meeting with regulatory authorities to discuss this data in the context of ongoing development with an aim to bring this therapy to patients in Europe, Asia-Pacific, and the U.S.”
Maybe attempting to do a worldwide rollout all at once? Something to silence the ‘fraudstains’ once and for all?
News 
Market Data 
Discover 
AI
